19. September 2009 02:38
Earlier this week, Eli Lilly & Company (NYSE:LLY) (Indianapolis, Indiana) announced a massive global layoff plan to better fortify the company's defenses against the plagues of profit-killing generics. The grim diagnosis impacts 5,500 employees who will lose their jobs by 2011. Lilly expects to cut $1 billion in expenses by the end of 2011 through the planned job cuts and other measures.
SOURCE: Industrial Info Resources
News-Medical.Net provides this medical information service in accordance
with these
terms and conditions.
Please note that medical information found
on this website is designed to support, not to replace the relationship
between patient and physician/doctor and the medical advice they may provide.